An Unsung Ally of Neuroscience: The Department of Veterans Affairs

Abstract

The annual appropriation for the Department of Veterans Affairs is substantially more than $40 billion. This is widely understood and appreciated as a grateful nation’s obligation to its veterans. What is less widely understood is the role of the VA in advancing clinical care, educating health care personnel, and supporting a diverse research portfolio. Clinical neuroscience is advanced in neurology, mental health, and geriatrics in VA, reflecting an aging population subject to neurodegenerative disorders and one in which mental illness is a significant factor. Spinal cord injury and research for new treatments for it are high priority areas within VA, and multiple sclerosis is also emerging as a priority. Research into stroke, Alzheimer disease, and Par-kinson disease is emphasized as is research on substance abuse, posttraumatic stress disorder (PTSD), and chronic mental illness. VA plays a major role in the training of mental health and neurology residents, supporting approximately 20% of the positions nationally in neurology. Research career development pro-grams foster developing neuroscientists. This report emphasizes the importance of VA to academic biomedicine in general, and Neuroscience in particular.

Keywords

Neuroscience Department of Veterans Affairs Neurodegenerative disease Academic medicine

Get full access to this article

View all access options for this article.

References

Booss J.

Change in the Department Of Veterans Affairs: what should be done?

Neurology 1997;49:338-340.

Hankin CS , Spiro A III , Miller D , Kazis L. Mental disorders and mental health treatment among U. S. Department of Veterans Af-fairs outpatients: the Veterans Health Study. Am J Psychiatry 1999;156:1924-1930.

Kurtzke JF . On the role of veterans in the development of neurology in the United States: a personal reflection. Neurology 1997;49:323-333.

Office of Research and Development. New knowledge advancing health care for veterans . 1999 Annual Report. Department of Veterans Affairs, Washington, DC.

Mattson RH , Cramer JA , Collins JF , Smith DB , Delgado-Escueta AV , Browne TR et al. Comparison of carbamezepine, phenobarbitol, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151.